DekaBank Deutsche Girozentrale’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-17,310
Closed -$1.69M 1210
2015
Q1
$1.69M Sell
17,310
-490
-3% -$47.8K 0.02% 478
2014
Q4
$1.61M Sell
17,800
-1,600
-8% -$145K 0.02% 495
2014
Q3
$1.33M Buy
19,400
+450
+2% +$30.9K 0.02% 480
2014
Q2
$1.99M Buy
18,950
+300
+2% +$31.4K 0.03% 418
2014
Q1
$1.55M Buy
18,650
+1,150
+7% +$95.4K 0.02% 413
2013
Q4
$1.16M Buy
17,500
+2,300
+15% +$152K 0.02% 408
2013
Q3
$964K Buy
15,200
+1,200
+9% +$76.1K 0.02% 440
2013
Q2
$601K Buy
+14,000
New +$601K 0.01% 440